Sees FY24 revenue $4B-$4.2B, consensus $4.09B.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on JAZZ:
- Jazz Pharmaceuticals Announces Board Changes and Appointments
- JAZZ Upcoming Earnings Report: What to Expect?
- Jazz Pharmaceuticals Welcomes New CFO with Strong Financial Expertise
- Jazz Pharmaceuticals appoints Philip Johnson as CFO
- Jazz to acquire KRAS inhibitor program from Redx Pharma for $10M upfront